(HLF) Herbalife Nutrition - Ratings and Ratios

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: KYG4412G1010

HLF: Weight Management, Targeted Nutrition, Energy, Sports, Outer Nutrition

Herbalife Ltd., a global leader in the health and wellness industry, operates in over 90 countries, offering a diverse range of nutrition and personal care products. The companys product portfolio includes weight management solutions such as meal replacements, protein shakes, and metabolism boosters; targeted nutrition products like herbal supplements and vitamins; energy and sports performance products; and outer nutrition offerings like skin, body, and hair care. Herbalife also provides educational materials and sales tools to its distributors. The companys distribution network includes independent service providers, sales representatives, and company-operated retail platforms. Formerly known as Herbalife Nutrition Ltd., the company rebranded as Herbalife Ltd. in April 2023. Founded in 1980, Herbalife is headquartered in Los Angeles, California, and has established itself as a key player in the direct sales industry, focusing on nutrition and wellness.

From a technical perspective, Herbalifes stock (NYSE:HLF) is currently trading at $6.86, with a 20-day moving average of $6.82. The stock is below its 50-day ($7.76) and 200-day ($7.64) moving averages, indicating bearish momentum. The average true range (ATR) of $0.50 suggests moderate volatility. On the fundamental side, the company has a market capitalization of $729.66 million, with a price-to-earnings (P/E) ratio of 2.88 and a forward P/E of 3.43. The price-to-sales (P/S) ratio of 0.14 reflects a low valuation relative to its revenue. However, the return on equity (RoE) of -31.79% raises concerns about profitability. Considering these factors, the stock may face near-term pressure due to its negative earnings growth and declining moving averages. Long-term investors may look for signs of operational turnaround and improved profitability to justify re-entry into the stock.

Additional Sources for HLF Stock

HLF Stock Overview

Market Cap in USD 730m
Sector Consumer Defensive
Industry Packaged Foods
GiC Sub-Industry Personal Care Products
IPO / Inception 2004-12-16

HLF Stock Ratings

Growth Rating -85.4
Fundamental -7.22
Dividend Rating 8.61
Rel. Strength -38.7
Analysts 3.25/5
Fair Price Momentum 4.76 USD
Fair Price DCF 34.80 USD

HLF Dividends

Dividend Yield 12m 0.00%
Yield on Cost 5y %
Annual Growth 5y 0.00%
Payout Consistency 34.4%

HLF Growth Ratios

Growth Correlation 3m -13.3%
Growth Correlation 12m -64%
Growth Correlation 5y -95.3%
CAGR 5y -29.30%
CAGR/Max DD 5y -0.32
Sharpe Ratio 12m -0.59
Alpha -36.66
Beta 0.040
Volatility 62.31%
Current Volume 1984.2k
Average Volume 20d 2105.2k
What is the price of HLF stocks?
As of May 09, 2025, the stock is trading at USD 6.99 with a total of 1,984,215 shares traded.
Over the past week, the price has changed by +5.43%, over one month by -0.99%, over three months by +33.40% and over the past year by -32.20%.
Is Herbalife Nutrition a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, Herbalife Nutrition is currently (May 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of -7.22 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of HLF as of May 2025 is 4.76. This means that HLF is currently overvalued and has a potential downside of -31.9%.
Is HLF a buy, sell or hold?
Herbalife Nutrition has received a consensus analysts rating of 3.25. Therefor, it is recommend to hold HLF.
  • Strong Buy: 1
  • Buy: 0
  • Hold: 2
  • Sell: 1
  • Strong Sell: 0
What are the forecast for HLF stock price target?
According to ValueRays Forecast Model, HLF Herbalife Nutrition will be worth about 5.2 in May 2026. The stock is currently trading at 6.99. This means that the stock has a potential downside of -26.32%.
Issuer Forecast Upside
Wallstreet Target Price 9.3 33.5%
Analysts Target Price 9.3 33.5%
ValueRay Target Price 5.2 -26.3%